References
- Walshe JM. Serum 'free' copper in Wilson disease. QJM. 2012;105(5):419–423.
- McMillin GA, Travis JJ, Hunt JW. Direct measurement of free copper in serum or plasma ultrafiltrate. Am J Clin Pathol. 2009;131:160–165.
- Walshe JM, Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically. Ann Clin Biochem. 2003;40(Pt 2):115–121.
- Twomey PJ, Viljoen A, House IA, et al. Relationship between serum copper, ceruloplasmin, and non-ceruloplasmin-bound copper in routine clinical practice. Clin Chem. 2005;51(8):1558–1559.
- Musci G, Polticelli F, Bonaccorsi di Patti MC. Ceruloplasmin-ferroportin system of iron traffic in vertebrates. World J Biol Chem. 2014;5(2):204–215.
- El Balkhi S, Poupon J, Trocello JM, et al. Determination of ultrafiltrable and exchangeable copper in plasma: stability and reference values in healthy subjects. Anal Bioanal Chem. 2009;394(5):1477–1484.
- El Balkhi S, Trocello JM, Poupon J, et al. Relative exchangeable copper: a new highly sensitive and highly specific biomarker for Wilson's disease diagnosis. Clin Chim Acta. 2011;412(23–24):2254–2260.
- Cabrera A, Alonzo E, Sauble E, et al. Copper binding components of blood plasma and organs, and their responses to influx of large doses of (65)Cu, in the mouse. Biometals. 2008;21(5):525–543.
- Favier A, Ruffieux D. Simple assay of serum copper fractions by ultrafiltration and flameless atomic absorption. Biol Trace Elem Res. 1988;18:145–160.
- Noubah AM, Al-Awqati MA. Ultrafiltrable copper and related analytes in maternal and cord blood. Clin Chem. 1990;36(6):860–864.
- Catalani S, Paganelli M, Gilberti ME, et al. Free copper in serum: an analytical challenge and its possible applications. J Trace Elem Med Biol. 2018;45:176–180.
- Forrer R, Gautschi K, Lutz H. Simultaneous measurement of the trace elements Al, As, B, Be, Cd, Co, Cu, Fe, Li, Mn, Mo, Ni, Rb, Se, Sr, and Zn in human serum and their reference ranges by ICP-MS. Biol Tr Elem Res. 2001;80:77–93.
- Musci G, Fraterrigo TZ, Calabrese L, et al. On the lability and functional significance of the type 1 copper pool in ceruloplasmin. J Biol Inorg Chem. 1999;4(4):441–446.
- Ramos D, Mar D, Ishida M, et al. Mechanism of copper uptake from blood plasma ceruloplasmin by mammalian cells. PLoS One. 2016;11(3):e0149516.
- Ding X, Xie H, Kang YJ. The significance of copper chelators in clinical and experimental application. J Nutr Biochem. 2011;22(4):301–310.
- Chutkow JG. Evidence for uptake of nonceruloplasminic copper in the brain: effect of ionic copper and amino acids. Proc Soc Exp Biol Med. 1978;158(1):113–116.
- Choi BS, Zheng W. Copper transport to the brain by the blood-brain barrier and blood-CSF barrier. Brain Res. 2009;1248:14–21.
- Liu N, Lo LS, Askary SH, et al. Transcuprein is a macroglobulin regulated by copper and iron availability. J Nutr Biochem. 2007;18(9):597–609.
- Han M, Lin Z, Zhang Y. The alteration of copper homeostasis in inflammation induced by lipopolysaccharides. Biol Trace Elem Res. 2013;154(2):268–274.
- Solovyev N, Ala A, Schilsky M, et al. Biomedical copper speciation in relation to Wilson's disease using strong anion exchange chromatography coupled to triple quadrupole inductively coupled plasma mass spectrometry. Anal Chim Acta. 2020;1098:27–36.
- El Balkhi S, Poupon J, Trocello JM, et al. Human plasma copper proteins speciation by size exclusion chromatography coupled to inductively coupled plasma mass spectrometry. Solutions for columns calibration by sulfur detection. Anal Chem. 2010;82(16):6904–6910.
- Schmitt F, Podevin G, Poupon J, et al. Evolution of exchangeable copper and relative exchangeable copper through the course of Wilson's disease in the long Evans Cinnamon rat. PLoS One. 2013;8:8232–8236.
- Woimant F, Djebrani-Oussedik N, Poujois A. New tools for Wilson's disease diagnosis: exchangeable copper fraction. Ann Transl Med. 2019;7(Suppl 2):S70.
- Ryan A, Nevitt SJ, Tuohy O, et al. Biomarkers for diagnosis of Wilson's disease. Cochrane Database Sys Rev. 2019;2019(11):1–52.
- Escobosa ARC, Wrobel K, Barrientos EY, et al. Effect of different glycation agents on Cu(II) binding to human serum albumin, studied by liquid chromatography, nitrogen microwave-plasma atomic-emission spectrometry, inductively-coupled-plasma mass spectrometry, and high-resolution molecular-mass spectrometry. Anal Bioanal Chem. 2015;407:1149–1157.